About: Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1999 (uk) article scientifique publié en 1999 (fr) im November 1999 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1999 (en) artículu científicu espublizáu en payares de 1999 (ast)
publication date	wds:Q73180919-E4B58B5D-9F46-4C70-9A9A-296D5946E761
publication date	1999-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73180919-58A58C6D-ACFC-4ABE-9664-7BCAFC9B6EB2
language of work or name	English
cites work	wds:Q73180919-101799ED-2396-4DAC-8106-6DF309045BDF wds:Q73180919-3ABF0147-22F0-4282-AF09-88675A071AAC wds:Q73180919-65ABAD4F-72BD-4AD6-A46C-492B3939BBD2 wds:Q73180919-8736668D-E1A2-4FF9-8049-1E76A1DC234D wds:Q73180919-97DEBB37-84AA-427C-8010-2AF5FDFB2773 wds:Q73180919-9A261C35-F28B-4B1E-97C7-2AB37F9A560D wds:Q73180919-ABD90C59-7033-49BC-8E75-4AE1A3408F0E wds:Q73180919-BD7C9962-D8A9-4A4C-9A00-20CE436B8F5A wds:Q73180919-C2DDDBFB-94C0-44CC-A9C6-725199C54E77 wds:Q73180919-C932A9F4-49D7-4351-9EF1-B48FB5546897 wds:Q73180919-CF372AD4-2004-4C2B-B099-62E937B98FE5 wds:Q73180919-D5FA67A7-EF42-4130-ACD4-3BF669E8B932 wds:Q73180919-DAED77A3-DB8B-4603-BE92-D356FDC184C1 wds:Q73180919-E4453927-BEE9-4C99-82ED-AC7F65B9EE79 wds:Q73180919-E5A01748-3EE2-4C1D-A176-BC246AA156C2 wds:Q73180919-E6DFEEE3-9DCB-4458-ADA2-0DC841716C6B wds:Q73180919-F6094C66-787A-420A-9B94-2D99C90C9FFD wds:Q73180919-F76F01AD-B9E8-48BC-986E-03108B1B0711 wds:Q73180919-FEC7912E-E43A-4A89-B898-10BD045A8458
cites work	Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Models for longitudinal data: a generalized estimating equation approach Transvaginal administration of progesterone. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone Luteal phase support and severe ovarian hyperstimulation syndrome Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation Experience with a novel vaginal progesterone preparation in a donor oocyte program Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone Endotoxins in culture medium for human in vitro fertilization Morphometric, immunohistological and three-dimensional evaluation of the endometrium of menopausal women treated by oestrogen and Crinone, a new slow-release vaginal progesterone
author name string	wds:Q73180919-0E2390E5-BE26-4502-9039-CD86B8AB3267 wds:Q73180919-1D9B6E12-6DA2-4A49-B679-61CA047D87DE wds:Q73180919-9B59CC4F-D4DC-4B4A-A92B-D17886F8C96D wds:Q73180919-C4A3F5BC-A672-4BFB-9A7B-F5D9557A6532 wds:Q73180919-D864B682-769D-4BB9-8686-972EC907A20A
author name string	D A Dumesic D G Hammitt D R Session M A Damario V T Goudas
rdfs:label	Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (en) Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (nl)
skos:prefLabel	Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (en) Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (nl)
name	Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (en) Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (nl)
title	wds:Q73180919-9B1256C6-F9B0-4E9A-8E71-C4427FBA601B
title	Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer (en)
page(s)	wds:Q73180919-FA29EC0E-7C7D-4919-A402-4B5630C10DED
page(s)	830-836
instance of	wds:Q73180919-8FF5F816-8502-43A5-8384-B10A21308E58
instance of	scholarly article
PubMed ID	wds:Q73180919-3ADA8D41-A6EF-450F-9896-BFF867C1DC24
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10560986
PubMed ID	10560986
published in	wds:Q73180919-3075343D-D1A9-4426-B9E4-B2D3A4973781
published in	Fertility and Sterility
issue	wds:Q73180919-5D1459B8-279B-4412-9CEB-6832E4DDE2A2
volume	wds:Q73180919-3FAB3E57-5E4A-47F6-947F-6CB67835D238
issue	5
volume	72
DOI	wds:Q73180919-EA4E0E27-B4BB-480C-A61B-5B428DDB2C25
DOI	http://dx.doi.org/10.1016/S0015-0282(99)00364-7
DOI	10.1016/S0015-0282(99)00364-7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73180919
is cites work of	Comparison between cytokine concentration in follicular fluid of poor and high responder patients and their influence of ICSI-outcome. Luteal phase support Evaluation of an optimal luteal phase support protocol in IVF. Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. Successful pregnancy and delivery after delaying the initiation of progesterone supplementation in a postmenopausal donor oocyte recipient Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers. Luteal phase support Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial Subclinical pregnancy losses among women undergoing in-vitro fertilization with ICSI.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software